Trials / Completed
CompletedNCT04766853
Verification of the Efficacy/safety of the Intratympanic Drug Delivery for Hearing Loss
Verification of the Efficacy / Safety of the Intratympanic Drug Delivery Vehicle for Treating Intractable Hearing Loss (pilot Study)
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This study is a prospective, randomized pilot study. To verify an efficacy and safety of the Intratympanic drug delivery vehicle, patients who have not responded to the existing standard treatment will be enrolled. Hearing test, endoscopy of tympanic membrane and CT scans will be conducted after intratympanic treatment for evaluation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexamethasone | Dexamethasone 5mg/ml |
| DRUG | Hyaluronic acid | Hyaluronic Acid 20mg/2ml |
Timeline
- Start date
- 2021-07-22
- Primary completion
- 2023-04-18
- Completion
- 2024-07-19
- First posted
- 2021-02-23
- Last updated
- 2024-10-24
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04766853. Inclusion in this directory is not an endorsement.